TOP STORIES

• REGULATORY Epkinly, Lunsumio to Face Price Cut of 2.7% under CEA
  May 15, 2025

• REGULATORY Japan’s Parliament Enacts Bill to Amend PMD Act
  May 15, 2025

• REGULATORY LDP Group Proposes Higher Cap on Social Security Budgets, Category-Based Drug Pricing
  May 14, 2025

• ACADEMIA Japan Consortium to Promote Domestic R&D of Cannabis-Derived Meds
  May 14, 2025

• BUSINESS J&J Taps Chris Rieger to Lead Japan Pharma Business
  May 13, 2025

• REGULATORY MHLW Council Deems 11 “Loss” Products as Medically Highly Necessary
  May 12, 2025

• BUSINESS Takeda on Course to Stable Growth as Late-Stage Assets Near Market
  May 9, 2025

• BUSINESS Lilly Japan Scores Double-Digit Growth for 2nd Year as Mounjaro Delivers
  May 9, 2025

• BUSINESS Shionogi to Buy Torii in 160 Billion Yen Deal, JT Pulls Plug on Pharma Biz
  May 8, 2025

• COMMENTARY New Grad Hires for Sales Reps Up after 5 Years of Decrease: FY2025 Survey
  May 8, 2025

• REGULATORY MHLW to Set Up Special Panel for High-Cost Medical Expense Benefit Program
  May 7, 2025

• BUSINESS Kyowa Kirin’s New Skipper Sees Further Growth Overseas, Vows to Cherish People
  May 1, 2025

• BUSINESS Astellas Gears Up for Xtandi Patent Cliff with Next-Gen Assets, Cost Cuts
  April 28, 2025

• BUSINESS Novo Nordisk Logs 3.6% Growth in Japan in 2024, Driven by Semaglutide
  April 28, 2025

• BUSINESS Sanofi Looks to Join Top 3 in Japan Pharma Market by 2030
  April 25, 2025

• REGULATORY MOF’s Spring Debate Puts Special Focus on CEA, More Aggressive Re-Pricing Eyed
  April 24, 2025

• REGULATORY Epkinly to Face Price Cuts under CEA Scheme
  April 24, 2025

• BUSINESS Takeda’s Japan Earnings Bottomed Out, Now on Pace to Growth from FY2025: Head
  April 23, 2025

• REGULATORY GSK’s Blenrep, Moderna RSV Jab Edge Closer to Japan Approval with Panel OK
  April 22, 2025

• REGULATORY MOF Tells LDP Members Govt Can Address Inflation with Current Budget Policy
  April 21, 2025

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »